The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[29-11-pm]Social Pharmacy 3, Pharmacoepidemiology/ Clinical pharmaceutical sciences 3, Pathophysiology (Cancer)

Sun. Mar 29, 2026 1:10 PM - 3:10 PM JST
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Room 11 (C304, Bldg. 2, Area 2 [3F])
Chair: Koji Suzuki, Tomomi Umemura
1:10 PM - 1:22 PM JST(4:10 AM - 4:22 AM UTC)

[29-11-pm01S]Prescription Practices of Inhalers for Long-Term Management in Pediatric Asthma Patients Using the Pediatric Medical Information Collection System

○Reika Shinchi1, Ryousuke Kumazawa2,1, Masayoshi Nakakuni3, Shinji Kobayashi4, Rui Saitou4, Kousuke Nakano3, Manabu Akazawa1 (1. Meiji Pharmaceutical University, 2. The University of Tokyo Hospital 3 National Center for Child Health and Development, 3. National Center for Child Health and Development, 4. Nature Insight)
1:22 PM - 1:34 PM JST(4:22 AM - 4:34 AM UTC)

[29-11-pm02S]Medication use for patients with elderly-onset rheumatoid arthritis

○Mirano Watanabe1, Kentaro Kawashimo1, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji pharmaceutical university)
1:34 PM - 1:46 PM JST(4:34 AM - 4:46 AM UTC)

[29-11-pm03S]Prescription Persistence of Newly Initiated ADHD Medications in Children: A Large-Scale Administrative Claims Database Analysis in Japan.

○Junsei Tanaka1, Ryutaro Suzuki1,2, Ryosuke Kumazawa1,3, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji pharmaceutical University, 2. Kitasato University School of Medicine, 3. The University of Tokyo Hospital)
1:46 PM - 1:58 PM JST(4:46 AM - 4:58 AM UTC)

[29-11-pm04S]Changes in Readmission Rates After Electroconvulsive Therapy According to Antidepressant Selection in Patients with Depression

○Takumi Miyoshi1, Taiyou Nishikawa2, Hiroyuki Muraoka2, Ryutaro Suzuki1,2, Ryoko Sakai1, Manabu Akazawa1, Ken Inada2 (1. Meiji pharmaceutical University, 2. Kitasato University School of Medicine)
1:58 PM - 2:10 PM JST(4:58 AM - 5:10 AM UTC)

[29-11-pm05S]Assessment of malignancy risk in patients with rheumatoid arthritis using large-scale claims data

○Kentaro Kawashimo1, Mirano Watanabe1, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji Pharmaceutical Univ.)
2:10 PM - 2:22 PM JST(5:10 AM - 5:22 AM UTC)

[29-11-pm06S]Association Between Single- vs. Multiple-Regimen Reports and MACE-related Event Signals among People Living with HIV: A FAERS Analysis

○Yuki Miura1, Shigeru Hasebe1, Chihiro Nishikawa1, Maho Kikuta1 (1. Fac. Pharm. Sci., Setsunan Univ.)
2:22 PM - 2:34 PM JST(5:22 AM - 5:34 AM UTC)

[29-11-pm07]Epigenomic Markers and Outcomes in Heavy Particle Therapy for Refractory Bone and Soft Tissue Sarcomas

○Toshiki Aiba1,2, Reiko Imai1, Makoto Shinoto1, Tetsuro Isozaki1, Akiko Hayashi2, Shinji Sato3, Harunobu Yunokawa3, Chizuru Tsuruoka2, Atsushi Tsuji1, Sumitaka Hasegawa1, Tatsuhiko Imaoka2, Toshiyuki Saito2 (1. QST.QST Hospital, 2. QST.NIRS, 3. Maze)
2:34 PM - 2:46 PM JST(5:34 AM - 5:46 AM UTC)

[29-11-pm08]The relationship between Tumor Vasculogenic Mimicry and Epithelial-Mesenchymal Transition

○Tetsuya Nomura1, Toma Narai1, Yurika Shiraki1, Ichiou Ogura1, Naoya Koizumi1, Yoshiyuki Shirasaka1, Naoki Utoguchi1 (1. Showa Pharm. Univ.)
2:46 PM - 2:58 PM JST(5:46 AM - 5:58 AM UTC)

[29-11-pm09]Modulation of EGFR signaling and drug responsiveness in pancreatic cancer cells by pancreatic stellate cell-derived factors

○Tetsufumi Takahashi1, Ayano Yoshida1, Haruhi Nagasaka1, Aoi Narumiya1, Erika Kouno1, Aki Ito1, Kazuto Isuzugawa1 (1. Yokohama Univ. Pharm)
2:58 PM - 3:10 PM JST(5:58 AM - 6:10 AM UTC)

[29-11-pm10]Evaluation of the Cytotoxic Effects of the Apoptosis-Inducing Nanoparticle CASP-LENA in Treatment-Resistant Human Epithelial Tumor-Derived Cell Lines

○Mayuko Yagi1, Jun Komano1 (1. Osaka Med. Pharm. Univ.)
Back to Category List